BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 33170477)

  • 1. The AGE-RAGE Axis and RAGE Genetics in Chronic Obstructive Pulmonary Disease.
    Sharma A; Kaur S; Sarkar M; Sarin BC; Changotra H
    Clin Rev Allergy Immunol; 2021 Apr; 60(2):244-258. PubMed ID: 33170477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implication of RAGE Polymorphic Variants in COPD Complication and Anti-COPD Therapeutic Potential of sRAGE.
    Malik P; Hoidal JR; Mukherjee TK
    COPD; 2021 Dec; 18(6):737-748. PubMed ID: 34615424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble receptor for advanced glycation end products in COPD: relationship with emphysema and chronic cor pulmonale: a case-control study.
    Miniati M; Monti S; Basta G; Cocci F; Fornai E; Bottai M
    Respir Res; 2011 Mar; 12(1):37. PubMed ID: 21450080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor for advanced glycation end products: a new theraputic target for chronic obstructive pulmonary disease?
    Chen L; Liu L; Wang T; Shen YC; Wen FQ
    Arch Med Res; 2013 Jan; 44(1):75-6. PubMed ID: 23287523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockout of RAGE ameliorates mainstream cigarette smoke-induced airway inflammation in mice.
    Chen M; Wang T; Shen Y; Xu D; Li X; An J; Dong J; Li D; Wen F; Chen L
    Int Immunopharmacol; 2017 Sep; 50():230-235. PubMed ID: 28704797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of HMGB1/RAGE/TLR4 signaling pathways in cigarette smoke-induced inflammation in chronic obstructive pulmonary disease.
    Lin L; Li J; Song Q; Cheng W; Chen P
    Immun Inflamm Dis; 2022 Nov; 10(11):e711. PubMed ID: 36301039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating soluble receptor for advanced glycation end products (sRAGE) as a biomarker of emphysema and the RAGE axis in the lung.
    Yonchuk JG; Silverman EK; Bowler RP; Agustí A; Lomas DA; Miller BE; Tal-Singer R; Mayer RJ
    Am J Respir Crit Care Med; 2015 Oct; 192(7):785-92. PubMed ID: 26132989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-23a-5p alleviates chronic obstructive pulmonary disease through targeted regulation of RAGE-ROS pathway.
    Chang C; Huang K; Xu X; Duan R; Yu T; Chu X; Chen C; Li B; Yang T
    Respir Res; 2024 Feb; 25(1):93. PubMed ID: 38378600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced glycation end products and their receptor in age-related, non-communicable chronic inflammatory diseases; Overview of clinical evidence and potential contributions to disease.
    Reynaert NL; Gopal P; Rutten EPA; Wouters EFM; Schalkwijk CG
    Int J Biochem Cell Biol; 2016 Dec; 81(Pt B):403-418. PubMed ID: 27373680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Ser82 RAGE Variant Affects Lung Function and Serum RAGE in Smokers and sRAGE Production In Vitro.
    Miller S; Henry AP; Hodge E; Kheirallah AK; Billington CK; Rimington TL; Bhaker SK; Obeidat M; Melén E; Merid SK; Swan C; Gowland C; Nelson CP; Stewart CE; Bolton CE; Kilty I; Malarstig A; Parker SG; Moffatt MF; Wardlaw AJ; Hall IP; Sayers I
    PLoS One; 2016; 11(10):e0164041. PubMed ID: 27755550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The receptor for advanced glycation end products and acute lung injury/acute respiratory distress syndrome.
    Guo WA; Knight PR; Raghavendran K
    Intensive Care Med; 2012 Oct; 38(10):1588-98. PubMed ID: 22777515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced glycation endproducts and their receptor in different body compartments in COPD.
    Hoonhorst SJ; Lo Tam Loi AT; Pouwels SD; Faiz A; Telenga ED; van den Berge M; Koenderman L; Lammers JW; Boezen HM; van Oosterhout AJ; Lodewijk ME; Timens W; Postma DS; Ten Hacken NH
    Respir Res; 2016 Apr; 17():46. PubMed ID: 27117828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The receptor for advanced glycation end products (RAGE) is involved in mitochondrial function and cigarette smoke-induced oxidative stress.
    Kwon OS; Decker ST; Zhao J; Hoidal JR; Heuckstadt T; Sanders KA; Richardson RS; Layec G
    Free Radic Biol Med; 2023 Feb; 195():261-269. PubMed ID: 36586455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble receptor for advanced glycation end-products and progression of airway disease.
    Iwamoto H; Gao J; Pulkkinen V; Toljamo T; Nieminen P; Mazur W
    BMC Pulm Med; 2014 Apr; 14():68. PubMed ID: 24758342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor for advanced glycation end-products and environmental exposure related obstructive airways disease: a systematic review.
    Haider SH; Oskuei A; Crowley G; Kwon S; Lam R; Riggs J; Mikhail M; Talusan A; Veerappan A; Kim JS; Caraher EJ; Nolan A
    Eur Respir Rev; 2019 Mar; 28(151):. PubMed ID: 30918021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AGEs, RAGEs and s-RAGE; friend or foe for cancer.
    Ahmad S; Khan H; Siddiqui Z; Khan MY; Rehman S; Shahab U; Godovikova T; Silnikov V; Moinuddin
    Semin Cancer Biol; 2018 Apr; 49():44-55. PubMed ID: 28712719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RAGE: a new frontier in chronic airways disease.
    Sukkar MB; Ullah MA; Gan WJ; Wark PA; Chung KF; Hughes JM; Armour CL; Phipps S
    Br J Pharmacol; 2012 Nov; 167(6):1161-76. PubMed ID: 22506507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The shedding-derived soluble receptor for advanced glycation endproducts sustains inflammation during acute Pseudomonas aeruginosa lung infection.
    Antonelli A; Di Maggio S; Rejman J; Sanvito F; Rossi A; Catucci A; Gorzanelli A; Bragonzi A; Bianchi ME; Raucci A
    Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):354-364. PubMed ID: 27913191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. All the "RAGE" in lung disease: The receptor for advanced glycation endproducts (RAGE) is a major mediator of pulmonary inflammatory responses.
    Oczypok EA; Perkins TN; Oury TD
    Paediatr Respir Rev; 2017 Jun; 23():40-49. PubMed ID: 28416135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic soluble receptor for advanced glycation endproducts is a biomarker of emphysema and associated with AGER genetic variants in patients with chronic obstructive pulmonary disease.
    Cheng DT; Kim DK; Cockayne DA; Belousov A; Bitter H; Cho MH; Duvoix A; Edwards LD; Lomas DA; Miller BE; Reynaert N; Tal-Singer R; Wouters EF; Agustí A; Fabbri LM; Rames A; Visvanathan S; Rennard SI; Jones P; Parmar H; MacNee W; Wolff G; Silverman EK; Mayer RJ; Pillai SG;
    Am J Respir Crit Care Med; 2013 Oct; 188(8):948-57. PubMed ID: 23947473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.